Canaccord Genuity Reiterates a 'Buy' on Insulet (PODD); Mixed Results - NDI Integration Complete

Canaccord Genuity reiterates a 'Buy' on Insulet Corporation (NASDAQ: PODD) price target of $27.00.

Analyst, William J. Plovanic, said, "We maintain our rating following mixed Q4/11 results with revenues in line and LPS slightly below our and consensus estimates. We believe the company is well positioned going forward as 2012 should be a transformational year with NDI fully integrated and the global launch of its gen2 OmniPod."

For an analyst ratings summary and ratings history on Insulet Corporation click here. For more ratings news on Insulet Corporation click here.

Shares of Insulet Corporation closed at $19.88 yesterday, with a 52 week range of $14.00-$23.33.

---

Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!

You May Also Be Interested In

• Barclays Maintains an 'Overweight' on Tidewater (TDW); Dayrates Climb, But Adjusting Numbers Lower on Expenses
• Compass Point Maintains a 'Neutral' on PNC Financial (PNC); RBC Addition Positive Offset By Increased Competition in C&I Lending
• UBS Lowers Estimates and PT on Lowe's (LOW) Messy Q1, But Bullish Case Remains

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS View

Related Entities

Genuity Capital Markets

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter